Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beumer, S
Right arrow Articles by Sixma, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beumer, S
Right arrow Articles by Sixma, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib

S Beumer, HF Heijnen, MJ IJsseldijk, E Orlando, PG de Groot and JJ Sixma

Department of Haematology, University Hospital Utrecht, The Netherlands.

We describe glycoprotein (GP) Ib as a mediator of adhesion to fibronectin, specifically in flow. A monoclonal antibody (MoAb) directed to the von Willebrand factor (vWF)-binding site on this receptor or the absence of this receptor on the platelet membrane, in the case of a patient with the Bernard-Soulier syndrome, reduced platelet coverage to fibronectin to approximately 30% of the control value. A MoAb directed to the GP Ib-binding site on vWF showed a similar effect. With washed platelets in the absence of plasma vWF, the inhibitory effect of the anti-GP Ib antibody was the same as with whole blood. No inhibition with the anti-GP Ib antibody was observed when we used blood from patients with severe von Willebrand disease (vWD) or from a patient with vWD type I (platelet low). Addition of vWF to vWD blood resulted in restoration of adhesion. Immunoelectron microscopy on platelets adhering to fibronectin showed that GP Ib was homogeneously distributed over the entire surface of the platelet. vWF was present at the central zone and the edges of the platelet and at the basal interface between the platelet and the fibronectin surface. No direct binding of vWF to fibronectin could be demonstrated. These data indicate that GP Ib-mediated adhesion to fibronectin fully depends on vWF and that normal levels of plasma or platelet vWF are sufficient for optimal adhesion to fibronectin. The data suggest that the presence of platelets during perfusion is a prerequisite for vWF to support platelet adhesion to fibronectin.

Volume 86, Issue 9, pp. 3452-3460, 11/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
Z. M. Ruggeri and G. L. Mendolicchio
Adhesion Mechanisms in Platelet Function
Circ. Res., June 22, 2007; 100(12): 1673 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Innerhofer, D. Fries, J. Margreiter, A. Klingler, G. Kuhbacher, B. Wachter, E. Oswald, E. Salner, B. Frischhut, and W. Schobersberger
The Effects of Perioperatively Administered Colloids and Crystalloids on Primary Platelet-Mediated Hemostasis and Clot Formation
Anesth. Analg., October 1, 2002; 95(4): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mazzucato, P. Spessotto, A. Masotti, L. De Appollonia, M. R. Cozzi, A. Yoshioka, R. Perris, A. Colombatti, and L. De Marco
Identification of Domains Responsible for von Willebrand Factor Type VI Collagen Interaction Mediating Platelet Adhesion under High Flow
J. Biol. Chem., January 29, 1999; 274(5): 3033 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. K. Magnusson and D. F. Mosher
Fibronectin : Structure, Assembly, and Cardiovascular Implications
Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1363 - 1370.
[Full Text] [PDF]


Home page
BloodHome page
G. H. van Zanten, H. F.G. Heijnen, Y. Wu, K. M. Schut-Hese, P. J. Slootweg, P. G. de Groot, J. J. Sixma, and R. Nieuwland
A Fifty Percent Reduction of Platelet Surface Glycoprotein Ib Does Not Affect Platelet Adhesion Under Flow Conditions
Blood, April 1, 1998; 91(7): 2353 - 2359.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Moroi, S. M. Jung, S. Nomura, S. Sekiguchi, A. Ordinas, and M. Diaz-Ricart
Analysis of the Involvement of the von Willebrand Factor-Glycoprotein Ib Interaction in Platelet Adhesion to a Collagen-Coated Surface Under Flow Conditions
Blood, December 1, 1997; 90(11): 4413 - 4424.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020